Formycon Partners with Teva and Klinge Biopharma for Commercialization of Aflibercept Biosimilar FYB203 (AHZANTIVE)
Formycon AG, in partnership with Teva Pharmaceuticals International GmbH and Klinge Biopharma GmbH, ...
read more
January 14, 2025
EMA CHMP Issues Positive Opinion for Aflibercept Biosimilar from Celltrion
The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued...
read more
December 18, 2024
More
OBN Spotlight TV: Interview with Jeff Todd, P...
March 14, 2025
AI in Ophthalmology: Top Artificial Intellige...
March 07, 2025
Upcoming 15 International Ophthalmology Congr...
November 13, 2024